Search research articles
Contact Us
Filters
Showing results (81-90 of 187) with videos related to
Page
of 19
Sort By:
Healthcare (Basel, Switzerland)
|
June 10, 2023
Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center
Lisa Cuba, Katja Schlichtig, Pauline Dürr, et al.
Clinical Pharmacokinetics
|
July 29, 2003
Pharmacokinetic interactions with rifampicin : clinical relevance
Mikko Niemi, Janne T Backman, Martin F Fromm, et al.
Scientific Reports
|
July 29, 2018
Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism
Stefan Selch, Anja Chafai, Heinrich Sticht, et al.
Journal of Clinical Medicine
|
April 12, 2022
Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications-A Systematic Analysis of SmPCs/PI of Major Drug Markets
Laura Weisbach, Anna K Schuster, Michael Hartmann, et al.
Pharmaceutics
|
April 3, 2021
Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters
Anne T Nies, Jörg König, Ute Hofmann, et al.
Amino Acids
|
July 10, 2020
Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and L-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells
Emir Taghikhani, Renke Maas, R Verena Taudte, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
March 7, 2022
[Economic aspects in the care of patients with new oral anticancer drugs: findings from the AMBORA trial]
Pauline Dürr, Katja Schlichtig, Sabine Krebs, et al.
Deutsches Arzteblatt International
|
January 3, 2023
The Psychopharmacological Treatment of People With Severe Dementia-Findings of a Cross-Sectional Study
Kristina Diehl, André Kratzer, Carolin Donath, et al.
Journal of Molecular and Cellular Cardiology
|
June 19, 2012
Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1)
Joachim Strobel, Maren Mieth, Beate Endress, et al.
Clinical Pharmacology and Therapeutics
|
December 6, 2022
Development in Prescriptions of Contraindicated and Potentially Harmful QT Interval-Prolonging Drugs in a Large Geriatric Inpatient Cohort From 2011 to 2021
Melanie I Then, Thomas Tümena, Anna Sledziewska, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 187) with videos related to
Sort By:
Page
of 19
Healthcare (Basel, Switzerland)
|
June 10, 2023
Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center
Lisa Cuba, Katja Schlichtig, Pauline Dürr, et al.
Clinical Pharmacokinetics
|
July 29, 2003
Pharmacokinetic interactions with rifampicin : clinical relevance
Mikko Niemi, Janne T Backman, Martin F Fromm, et al.
Scientific Reports
|
July 29, 2018
Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism
Stefan Selch, Anja Chafai, Heinrich Sticht, et al.
Journal of Clinical Medicine
|
April 12, 2022
Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications-A Systematic Analysis of SmPCs/PI of Major Drug Markets
Laura Weisbach, Anna K Schuster, Michael Hartmann, et al.
Pharmaceutics
|
April 3, 2021
Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters
Anne T Nies, Jörg König, Ute Hofmann, et al.
Amino Acids
|
July 10, 2020
Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and L-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells
Emir Taghikhani, Renke Maas, R Verena Taudte, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
March 7, 2022
[Economic aspects in the care of patients with new oral anticancer drugs: findings from the AMBORA trial]
Pauline Dürr, Katja Schlichtig, Sabine Krebs, et al.
Deutsches Arzteblatt International
|
January 3, 2023
The Psychopharmacological Treatment of People With Severe Dementia-Findings of a Cross-Sectional Study
Kristina Diehl, André Kratzer, Carolin Donath, et al.
Journal of Molecular and Cellular Cardiology
|
June 19, 2012
Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1)
Joachim Strobel, Maren Mieth, Beate Endress, et al.
Clinical Pharmacology and Therapeutics
|
December 6, 2022
Development in Prescriptions of Contraindicated and Potentially Harmful QT Interval-Prolonging Drugs in a Large Geriatric Inpatient Cohort From 2011 to 2021
Melanie I Then, Thomas Tümena, Anna Sledziewska, et al.
Page
of 19